1 / 1

C. Acevedo, M. Morini, M. Gomez, M.E. Almagro, M.G. Ropelato

Measurement of salivary cortisol levels by an automated electrochemiluminescence immunoassay method (ECLIA) Evaluation of analytical performance. C. Acevedo, M. Morini, M. Gomez, M.E. Almagro, M.G. Ropelato

jade-nunez
Download Presentation

C. Acevedo, M. Morini, M. Gomez, M.E. Almagro, M.G. Ropelato

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Measurement of salivary cortisol levels by an automated electrochemiluminescence immunoassay method (ECLIA) Evaluation of analytical performance C. Acevedo, M. Morini, M. Gomez, M.E. Almagro, M.G. Ropelato Laboratorio de Medicina S.A. Olaya 1644. Bs. As. Argentina. e-mail: endocrinologia@labmedicina.com BACKGROUND The diagnosis and treatment of Cushing’s Syndrome represents a challenge in clinical endocrinology as the features of endogenous hypercortisolism are common to other clinical conditions. The lack of circadian rhythm in adrenal cortical secretion is one of the hallmarks of this disease. Salivary cortisol reflects the unbound, biologically active form of serum cortisol. Consequently, the measurement of late evening salivary cortisol is especially useful for evaluating ambulatory patients and for the pediatric population, given it is a noninvasive method OBJECTIVE To evaluate the analytical performance of the ECLIA method for the measurement of salivary cortisol • MATERIALS Y METHODS • An automated immunoassay with electrochemiluminescent signal (Modular E170 Roche) was used • Allowable total error (TEa) was established as 3CVi = 20% • Samples of saliva were obtained from healthy volunteers (13 women and 7 men) between 26 and 45 years of age. BMI<25 kg/m² .These were collected at 8:00, 15:00 and 23:00 hours. • Precision: repeatability(CVr) and intermediate precision (CVi) of two levels of concentration were evaluated with pools of samples of saliva (P1 and P2) according to EP15-A2 CLSI protocol • P1: 8.3 nmol/l • P2: 16.6 nmol/l • Data were compared with manufacturer´s claims • Thelimit of quantification ( LoQ), defined as the lowest concentration that can be quantified with an intermediate precision, CVi <20%, was determined based on Spenser et al. (Demmers LM and Spencer LA (eds.) National Academy of Clinical Biochemistry Support for the diagram and monitoring of thyroid disease. 2003, 13:4-126)Five concentrations of saliva near the LoQ claimed were run for 10 days • The reference interval (RI) of 8:00 am and 15:00 pm proposed by the manufacturer was ascertained following C28 A3 CLSI protocol. The 95 percentile was estimated for the 23:00 hour samples as this RI was not reported as product information • Linearity was verified across 0.74 – 17.00 nmol/L, an interval representing the lower zone of the measuring range ( 0.50 – 1750 nmol/l) LINEARITY RESULTS Cortisol circadian rhythm Women Salivary Cortisol (nmol/L) Cort 8hs Cort 15 hs Cort 23hs Men Salivary Cortisol (nmol/L) Reference Interval Histogram 8:00 hours 15:00 hours Cort 8hs Cort 15 hs Cort 23hs Range Tested: 0.74 to 17.0 nmol/L • CONCLUSIONS • The assessment of the ECLIA analytical performance enabled us to verify the precision and reference interval specifications for salivary cortisol claimed by the manufacturer . • The LoQ obtained allowed us to ensure an adequate performancein the clinical decision levels. • FUTURE OBJECTIVES • Confirming our preliminary results of the reference interval in the 23:00 hour samples will be of great value in the evaluation of the hypercortisolism disorders. • Our mayor goalis to establish the laboratory´s pediatric RI for salivary cortisol.

More Related